InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Godlewski Laura Lee, Vice-Président Financier. Officer active across 1 company, notably HTG Molecular Diagnostics, INC. In total, 6 disclosures have been published. Activity tracked since 10 June 2021. The latest transaction was disclosed on 9 December 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
1,000 shares@ US$0.4253.5% of flowCommon StockSEC:0001209191-22-061005:0
1,000 shares@ US$0.4764.0% of flowCommon StockSEC:0001209191-22-036959:0
1,000 shares@ US$3.561528.5% of flowCommon StockSEC:0001209191-21-069778:0
1,000 shares@ US$3.561527.5% of flowCommon StockSEC:0001209191-21-069778
672 shares@ US$3.918518.8% of flowCommon StockSEC:0001209191-21-040447
672 shares@ US$3.918519.5% of flowCommon StockSEC:0001209191-21-040447:0
6 of 6 declarations
About Godlewski Laura Lee
Laura Lee Godlewski is the VP Finance and Principal Accounting Officer at HTG MOLECULAR DIAGNOSTICS, INC. She is responsible for the financial management and accounting of the company. Her role is essential in ensuring HTG's financial health and regulatory compliance.
